CD36 deficiency predisposing young children to fasting hypoglycemia

Metabolism: Clinical and Experimental

Volumn 60, Issue 6, 2011, Pages 881-887

  Nagasaka, Hironori ^a   Yorifuji, Tohru ^b   Takatani, Tomozumi ^c   Okano, Yoshiyuki ^d   Tsukahara, Hirokazu ^e   Yanai, Hidekatsu ^f   Hirano, Ken Ichi ^g   Hui, Shu Ping ^h   Hirayama, Satoshi ⁱ   Ito, Tetsuya ^j   Chiba, Hitoshi ^k   Miida, Takashi ⁱ  

^a CHIBA CHILDREN'S HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

ⁱ JUNTENDO UNIVERSITY   (Japan)

^j NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^k HOKKAIDO UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; KETONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANTIGEN EXPRESSION; ARTICLE; CARBOHYDRATE METABOLISM; CD36 ANTIGEN DEFICIENCY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE PREDISPOSITION; FATTY ACID METABOLISM; FEMALE; GENE MUTATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IMMUNE DEFICIENCY; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MONOCYTE; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTE; WILD TYPE;

ANTIGENS, CD36; BLOOD GLUCOSE; CHILD, PRESCHOOL; FASTING; FATTY ACIDS; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOGLYCEMIA; INFANT; INSULIN; KETONE BODIES; MALE; MUTATION; OXIDATION-REDUCTION; PHENOTYPE; PROSPECTIVE STUDIES;

EID: 79956098401     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.08.008     Document Type: Article

References (28)

1. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction and transfusion medicine. Blood 1992;80:1105-15.
2. Ge Y, Eighetany MT. CD36: multiligand molecule. Lab Hematol 2005;11:31-7.
3. Silverstein RL, Asch AS, Nachman RL. Glycoprotein IV mediated thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest 1989;84:546-52. (Pubitemid 19196986)
4. Nozaki S, Kashiwagi H, Yamashita S, et al. Reduced uptake of oxidized low-density lipoprotein in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 1995;96:1859-65.
5. Yoshizumi Y, Nozaki S, Fukuchi K, Yamazaki K, Fukuchi K, Maruyama T, et al. Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects. J Nuclear Med 2000;41:1134-8. (Pubitemid 30463994)
6. Yamamoto N, Akamatsu H, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994;83:392-7. (Pubitemid 24030564)
7. Kashiwagi H, Tomiyama Y, Honda S, et al. Molecular basis of CD36 deficiency. Evidence that a 478C→T substitution (proline90→serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 1995;95:1040-6.
8. Kashiwagi H, Tomiyama Y, Nozaki S, et al. A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency. Arterioscler Thromb Vasc Biol 1996;16:1026-32. (Pubitemid 26266903)
9. Yanai H, Chiba H, Fujiwara H, et al. Phenotype-genotype correlation in CD36 deficiency types I and II. Thromb Haemost 2000;84:436-41.
10. Furuhashi M, Ura N, Nakata T, Shimamoto K. Insulin sensitivity and lipid metabolism in human CD36 deficiency. Diabetes Care 2003;26:471-4. (Pubitemid 36929076)
11. Aitman JA, Glazier AM, Wallace CA, et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999;21:76-83. (Pubitemid 29036288)
12. Miyaoka K, Kuwasako T, Hirano K, Nozaki S, Yamashita S, Matsuzawa Y. CD36 deficiency with insulin resistance. Lancet 2001;357:686-7.
13. Masuda D, Hirano K, Oku H, et al. Chylomicron remnants are increased in the postprandial state in CD36 deficiency. J Lipid Res 2009;50:999-1011.
14. Yanai H, Chiba H, Morimoto M, et al. Metabolic changes in human CD36 deficiency displayed by glucose loading. Thromb Haemost 2001;86:995-9. (Pubitemid 32975823)
15. Teraguchi M, Ikemoto Y, Unishi G, Ohkohchi H, Kobayashi Y. Influence of CD36 deficiency on heart disease in children. Circ J 2004;68:435-8. (Pubitemid 38657531)
16. Haworth JC, Coodin FJ. Idiopathic spontaneous hypoglycemia in children. Report of seven cases and review of the literature. Pediatrics 1960;25:748-65.
17. Daly LP, Osterhoudt KC, Weinzimer SA. Presenting features of idiopathic ketotic hypoglycemia. J Emerg Med 2003;25:39-43. (Pubitemid 36829163)
18. Pershad JMonroe K, Atchison J. Childhood hypoglycemia in an urban emergency department epidemiology and a diagnostic approach to the problem. Pediatr Emerg Care 1996;14:268-71. (Pubitemid 28396836)
19. Roe CR, Ding JH. Mitochondria fatty acid oxidation disorders. In: Scriver CR, Baudet AL, Valle D, Sly WS, editors. The metabolic and molecular bases of inherited disease. 8th ed. New-York: McGraw-Hill; 2001. p. 2297-326.
20. Shigematsu Y, Hata I, Kikawa Y, et al. Modifications in electrospray tandem mass spectrometry for a neonatal-screening pilot study in Japan. J Chromatgr B Biomed Sci Appl 1999;731:97-103. (Pubitemid 29376418)
21. Kashiwagi H, Tomiyama Y, Kosugi S, et al. Identification of molecular defects in a subject with type I CD36 deficiency. Blood 1994;83:3545-52. (Pubitemid 24175544)
22. Hanawa H, Watanabe K, Nakamura T, et al. Identification of cryptic splice site, exon skipping, and novel point mutations in type I CD36 deficiency. J Med Genet 2002:39286-91.
23. Storch J, Thumser AE. The fatty acid transporter function of fatty acid-binding proteins. Biochim Biophys Acta 2000;1486:28-44. (Pubitemid 30336790)
24. Storch J, Veerkamp JH, Hsu KT. Similar mechanisms of fatty acid transfer from human anal rodent fatty acid-binding proteins to membranes: liver, intestine, heart muscle, and adipose tissue FABPs. Mol Cell Biochem 2002;239:25-33. (Pubitemid 35385792)
25. Koonen DP, Glatz JF, Bonen A, Leiken JJ. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim Biophys Acta 2005;1736:163-80. (Pubitemid 41423701)
26. Kuang M, Febbraio M, Wagg C, Lopaschuk GD, Dyck JR. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise heart before or after ischemia. Circulation 2004;109:1550-7. (Pubitemid 38420185)
27. Febbraio M, Abumrad NA, Hajjar DP, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999;274:19055-62.
28. Bonnefont JP, Specola NB, Vassault A, et al. The fasting test in paediatrics: application to the diagnosis of pathological hypo-and hyperketotic states. Eur J Pediatr 1990;150:80-5.